15-75675928-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001897.5(CSPG4):c.6591G>T(p.Glu2197Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000181 in 1,598,172 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001897.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CSPG4 | NM_001897.5 | c.6591G>T | p.Glu2197Asp | missense_variant | 10/10 | ENST00000308508.5 | NP_001888.2 | |
CSPG4 | XM_047432196.1 | c.5529G>T | p.Glu1843Asp | missense_variant | 10/10 | XP_047288152.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CSPG4 | ENST00000308508.5 | c.6591G>T | p.Glu2197Asp | missense_variant | 10/10 | 1 | NM_001897.5 | ENSP00000312506.5 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000916 AC: 22AN: 240108Hom.: 0 AF XY: 0.0000842 AC XY: 11AN XY: 130716
GnomAD4 exome AF: 0.000194 AC: 281AN: 1445846Hom.: 0 Cov.: 32 AF XY: 0.000195 AC XY: 140AN XY: 719390
GnomAD4 genome AF: 0.0000525 AC: 8AN: 152326Hom.: 0 Cov.: 33 AF XY: 0.0000671 AC XY: 5AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 16, 2024 | The c.6591G>T (p.E2197D) alteration is located in exon 10 (coding exon 10) of the CSPG4 gene. This alteration results from a G to T substitution at nucleotide position 6591, causing the glutamic acid (E) at amino acid position 2197 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at